Mission: Eliminating Unnecessary Pain
Pain Care Labs (a dba of MMJ Labs) was established in 2006 by pediatric emergency physician and pain researcher Amy Baxter. Distressed by other doctors’ failure to control needle pain, Dr. Baxter set out to develop reusable, physiologic products for home and hospital.
Initial R&D funded by the Mayday Foundation and the NIH launched the flagship product Buzzy®, a palm sized device combining cold and mechanical stimulation. The frequency Dr. Baxter identified is now proven to most effectively inhibit pain, improve muscle soreness, blood flow, recovery and more. Since its May 1 2009 launch, Buzzy® has controlled needle pain for over 37 million procedures in 27 countries. Buzzy is now in over 5,000 hospitals and clinics, with over 250,000 units sold.
With multiple patents and FDA 510(k) clearances to control pain from IVs, blood draws, cosmetic injections, and injuries and treat myofascial trigger point pain, muscle restriction and tension, the company also created the VibraCool® Cryo-vibration product line. In 2019, studies showed VibraCool’s M-Stim pain relief was 2-3.4 times superior to electrical stimulation (TENS) for physical therapy; another demonstrated 35% fewer opioid tablets after knee surgery. A sophisticated low back pain device is currently in clinical trials and expected to release in 2021.
Eliminate unnecessary pain
We are moms and women who know healthcare can do better. Through a deep understanding of science, we create easy-to-use devices to address suffering and fear: power over pain.
MD, FAAP, FACEP / Inventor, Founder, and CEO
Dr. Baxter directs innovation, invention, operations and strategy for Pain Care Labs. After graduating from Yale University and Emory Medical School, as a double boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research while also founding Pain Care Labs (initially called MMJ Labs). Accomplishments include multiple NIH SBIR Fast-Tracks and review panel service, writing and overseeing patent strategy, and successfully pursuing 510(k) FDA clearances. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person,” and the Most Innovative CEO from Georgia Bio. National and international lecturing highlights include Exponential Medicine “Future of Pain Management”, TEDx, State Department VentureWell keynote, and TEDMED.